Dark

Check out our Level2View

AMPE
AMPIO PHARMS INC
stock OTC

Inactive

May 8, 2026

0.1831USD-71.391%(-0.4569)372

Pre-market

0.00USD-100.000%(-0.64)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 6, 2022

08:31AM EST Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect PR Newswire

Dec 16, 2021

08:43AM EST Ampio Pharmaceuticals CEO Mike Martino Issues Letter To Stockholders Benzinga

08:39AM EST Ampio Pharma CEO Mike Martino Issues Letter To Stockholders RTTNews

08:36AM EST Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders PR Newswire

Dec 13, 2021

08:32AM EST Ampio Pharma Prices 25M Share, 15M Shares Via Warrants At Combined Price $0.90/Unit Benzinga

08:31AM EST AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT PR Newswire

Nov 29, 2021

04:01PM EST Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike PR Newswire

Nov 23, 2021

05:31PM EST Ampio Pharmaceuticals Announces Shareholder / Business Update Call with its CEO PR Newswire

Nov 22, 2021

09:41AM EST Biopharmaceutical company Ampio Pharmaceuticals (AMPE) announced Monday that Mike Macaluso is taking a one-year medical leave of absence from his role as Chairman and CEO, effective immediately, as he is undergoing medical treatment. RTTNews

09:19AM EST Ampio Pharmaceuticals Says Board Member Michael Martino To Become Interim Chairman And CEO Benzinga

09:18AM EST Ampio Pharma CEO Mike Macaluso Taking One-year Medical Leave Of Absence, Effective Immediately RTTNews

09:15AM EST Board Member Michael Martino to Become Interim Chairman and CEO of Ampio PR Newswire

Nov 10, 2021

05:07PM EST Ampio Pharmaceuticals Q3 EPS $(0.02), Inline Benzinga

04:01PM EST Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and PR Newswire

08:23AM EST The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance Benzinga

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Oct 28, 2021

09:16AM EDT Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Third Quarter Financial PR Newswire

Oct 13, 2021

09:19AM EDT Ampio Promotes Holli Cherevka To President And COO RTTNews

09:15AM EDT Ampio Pharmaceuticals Strengthens Management Team and Board of Directors PR Newswire

Sep 28, 2021

10:19AM EDT Ampio Pharmaceuticals Granted U.S. Patent Titled 'Methods for treating diseases associated with respiratory viruses' Benzinga

Sep 21, 2021

09:20AM EDT Ampio Receives Approval From The Drugs Controller General Of India To Commence AP-019 Phase II Study In India RTTNews

09:17AM EDT Ampio Pharma Reports Received Approval From Drugs Controller General Of India To Begin AP-019 Phase 2 Study In India Benzinga

09:15AM EDT Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of PR Newswire

Sep 15, 2021

02:54PM EDT Why Ampio Pharmaceuticals Stock Is Trading Higher Today Benzinga

09:42AM EDT Ampio Pharmaceuticals (AMPE) announced positive results from AP-013, a randomized, saline-controlled, double-blind Phase III clinical study evaluating the efficacy of an intra-articular (IA) injection of Ampion in adults with pain due to severe osteoarthritis of the knee or OAK. RTTNews

09:19AM EDT Ampio : Ampion Shows Significant Reduction In Pain And Improvement In Function At 12 Weeks In Severe OAK Patients RTTNews

09:16AM EDT Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of PR Newswire

09:00AM EDT EXCLUSIVE: Ampio Pharma Says Plans To Meet With FDA To Discuss Phase 3 Results, Biologics License Application For Ampion, But Does Not Specify A Timeline Benzinga

09:00AM EDT EXCLUSIVE: Ampio Pharma Says Has Cash Runway Of ~12 Months, Will 'provide sufficient near-term liquidity and flexibility to support existing business operations' Benzinga

09:00AM EDT EXCLUSIVE: Ampio Pharma Says Statistical Analysis Of Ampion Study For 725 Patients Co. Believes Were Not Impacted By COVID-19 Pandemic Showed Statistical Significant Reduction In Pain (p=0.026) At 12 Weeks vs Saline Control Benzinga

09:00AM EDT EXCLUSIVE: Ampio's Ampion Shows Benefit In Late-Stage Knee Osteoarthritis Study Benzinga

09:00AM EDT EXCLUSIVE: Ampio Pharma Reports Sensitivity Analysis Of Ampion Showed Statistically Significant Impact On Trial During COVID-19 Pandemic Benzinga

09:00AM EDT EXCLUSIVE: Ampio Pharma Reports Top-Line Results From Study Evaluating Efficacy Of Intra-Articular Injection Of Ampion In Adults With Pain Due To Severe Osteoarthritis Of The Knee: Showed Statistically Significant Reduction In Pain At 12 Weeks Benzinga

Aug 13, 2021

09:16AM EDT Ampio Pharmaceuticals Announces New Research Manuscript On Anti-Inflammatory Mode Of Action Benzinga

09:15AM EDT Ampio Pharmaceuticals Announces Important New Research Manuscript on PR Newswire

Aug 12, 2021

09:17AM EDT Ampio Pharmaceuticals Reminds Stockholders To Vote Shares In Advance Of 2021 Annual Meeting RTTNews

09:15AM EDT Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 PR Newswire

Aug 11, 2021

09:15AM EDT Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences PR Newswire

Aug 4, 2021

04:50PM EDT Ampio Pharmaceuticals Q2 EPS $(0.02), Inline Benzinga

04:01PM EDT Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and PR Newswire

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Jul 29, 2021

09:15AM EDT Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd PR Newswire

Jul 28, 2021

09:20AM EDT Ampio To Present At October Scientific Conference Evidence Of Ampion's Role In Treating Lupus Nephritis, COVID-19 Benzinga

09:15AM EDT Lupus Erythematosus (LUPUS 2021) & 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA) PR Newswire

09:01AM EDT Ampio To Present At October Scientific Conference Evidence Of Co.'s Role In Treating Lupus Nephritis, COVID-19 Benzinga

09:00AM EDT EXCLUSIVE: Ampio Pharma Highlights Upcoming Presentation Of Data For Ampion At Int'l. Congress On Systemic Lupus Ertyhematosus, Oct. 6-9, 2021 Benzinga

Jun 25, 2021

09:46AM EDT Ampio's Phase 2 Study Of Inhaled Ampion In COVID-19 Patients Gets Underway Benzinga

09:18AM EDT Ampio Says Patient Randomization And Dosing In AP-019 Phase II Study Is Underway RTTNews

09:15AM EDT Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 PR Newswire

09:01AM EDT EXCLUSIVE: Ampio Pharmaceuticals Announces Patient Randomization And Dosing In AP-019 Phase II Study Of Inhaled Ampion In COVID-19 Respiratory Distress Benzinga

09:00AM EDT Ampio Pharmaceuticals Announces Patient Randomization And Dosing In AP-019 Phase II Study Of Inhaled Ampion In COVID-19 Respiratory Distress Benzinga

Jun 18, 2021

09:16AM EDT Ampio Pharmaceuticals, Inc. to Join the Russell 2000(r) Index and Russell PR Newswire

09:00AM EDT Exclusive: Ampio Pharmaceuticals Set To Join Russell 2000 Index, Russell 3000 Index On June 28 Benzinga

Jun 17, 2021

09:28AM EDT Ampio Updates On Osteoarthritis Of The Knee (OAK) Program RTTNews

09:15AM EDT Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program, Reiterates PR Newswire

09:00AM EDT Ampio Pharmaceuticals Highlights Newly Integrated Data From 4 Previous Clinical Trials Of Osteoarthritis Of The Knee Program Benzinga

Jun 15, 2021

08:07AM EDT The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda Benzinga

07:36AM EDT Ampio Pharmaceuticals (AMPE) Tuesday said it has received approval from the FDA to expand enrollment of the mid-stage study of its lead drug Ampion in Covid-19 to India. RTTNews

07:11AM EDT Ampio Stock Jumps On Enrollment Expansion Of Mid-Stage COVID-19 Trial To India With Inhaled Ampion Benzinga

06:17AM EDT Ampio Pharmaceuticals Receives Approval To Expand Enrollment Of AP-019 Phase II Study To India Benzinga

06:17AM EDT Ampio Receives Regulatory Approval To Expand Enrollment Of Its AP-019 Phase II Study To India RTTNews

06:15AM EDT Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 PR Newswire

Jun 14, 2021

06:15AM EDT Ampio Pharmaceuticals to Present at the 2021 International Society for PR Newswire

Jun 11, 2021

09:15AM EDT Ampio Pharmaceuticals to Participate in the Alliance Global Partners' Virtual PR Newswire

May 21, 2021

09:15AM EDT Ampio Pharmaceuticals to Present Poster at the International Society for PR Newswire

May 10, 2021

09:22AM EDT Ampio Receives IRB Approval To Commence Enrollment In Its AP-018 Phase I Study Using Inhaled Ampion RTTNews

09:16AM EDT Ampio Pharmaceuticals Receives Investigational Review Board Approval for its PR Newswire

08:45AM EDT EXCLUSIVE: Ampio Pharmaceuticals Approved For Clinical Study Of Lead Drug In Long-Term Respiratory COVID-19 Symptoms Benzinga

08:45AM EDT Ampio Pharmaceuticals Says Receives Investigational Review Board Approval For Phase I Long COVID-19 Trial (AP-018) Using Inhaled Ampion With Patients Exhibiting Prolonged Respiratory COVID-19 Symptoms Benzinga

08:35AM EDT A Study to Evaluate Ampio Pharmaceuticals Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID) Posted to ClinicalTrials Website Benzinga

May 5, 2021

04:30PM EDT Ampio Pharmaceuticals Q1 EPS $(0.02), Inline Benzinga

04:02PM EDT Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and PR Newswire

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

Apr 27, 2021

10:39AM EDT Ampio Pharma's Inhaled COVID-19 Treatment Shows 78% Improvement In All-Cause Mortality Benzinga

09:18AM EDT Ampio Pharmaceuticals Says Ampion Met PRimary Endpoint And Reduced All-Cause Mortality In COVID-19 Respiratory Distress By Nearly 80% Benzinga

09:16AM EDT Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion(tm) in PR Newswire

09:16AM EDT Ampion(tm) Reduces All-cause Mortality in COVID-19 Respiratory Distress by PR Newswire

Apr 21, 2021

09:16AM EDT Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial PR Newswire

Apr 19, 2021

09:17AM EDT Ampio Highlights Preclinical Research Findings For Ampion Benzinga

09:16AM EDT Research Shows Ampion(tm) Gene Regulation Mimics the Anti-Inflammatory Effects PR Newswire

Apr 6, 2021

09:25AM EDT Ampio: Study Shows Ampion Inhibits Inflammatory Pathway Intypes Of Immune Cells Implicated In COVID-19&Lupus Nephritis RTTNews

09:15AM EDT Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway PR Newswire

Apr 1, 2021

09:57AM EDT Ampio Pharmaceuticals is Building on its Progress in Tackling Osteoarthritis and COVID-19 Respiratory Issues Benzinga

Mar 29, 2021

09:16AM EDT Ampio Pharmaceuticals to Present at the International Society for Aerosols in PR Newswire

Mar 24, 2021

02:20PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals CEO Michael Macaluso Says COVID Has Been A 'Benefit' For Company Because Of Development Of Inflammatory Ampion Benzinga

02:19PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals CEO Michael Macaluso Says Also Will Conduct Ampion Inflammatory Trial In U.S. As Well As Israel Benzinga

02:18PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says Ampion IV Study On 'Similar Trajectory' As Inhalation Ampion Benzinga

02:17PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says Co Is 'Looking Forward' To Following Up With The FDA 'Soon' On Ampion OAK Treatment Trial Suspension Benzinga

02:15PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says Ampion OAK Treatment Was Suspended Due To COVID-19 Pandemic Benzinga

02:13PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says Global Phase I/II Clinical Trail For Ampion IV Therapy In COVID-19 Patients Study To Initiate In Israel Benzinga

02:12PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says FDA Approved IND For Ampion IV Treatment For COVID-19 Patients; Says Demonstrated Safety For First-In-Human Clinical Trails Benzinga

02:10PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says Preliminary Data For Inhaled Ampion Phase 1 Trial 'Demonstrated An Improvement In All-Cause Mortality' Benzinga

02:09PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Highlights COVID Trials Currently Underway At Co Including Inhalation Study, IV Study, PASC/Long-Hauler Study; Says Expects Top-Line Results On Inhalation Study In Early Q2 2021 Benzinga

02:06PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Highlights Recent Collaboration With Vanderbilt University Benzinga

02:05PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says Ampion Targets 'Multiple Pathways' In Immune Responses Benzinga

02:05PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Says Ampio Blocks Transcriptions In Hyperactive Cycle Of Inflammation Benzinga

02:04PM EDT From BZ Biotech Conference: Ampio Pharmaceuticals COO Holli Cherevka Highlights Co's Ampion Benzinga

09:02AM EDT Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Mar. 24, 2021: PRPH, QLGN, SRNE, GLSI, AMPE Benzinga

Mar 23, 2021

07:12PM EDT Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021 Benzinga

Mar 19, 2021

09:15AM EDT Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap Conference PR Newswire

Mar 16, 2021

09:19AM EDT Ampio Details Early Positive Results For Inhaled Ampion In COVID-19 Respiratory Distress RTTNews

09:18AM EDT Ampio Pharmaceuticals Highlights Prelim. Results Of AP-014 Phase I Trial Utilizing Ampion In COVID-19 Respiratory Distress; Says Ampion Demonstrated Improvement In All-Cause Mortality, Patients Required Less Hospitalization Time Benzinga

09:15AM EDT Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in PR Newswire

Mar 10, 2021

04:01PM EST Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference PR Newswire

Mar 4, 2021

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

Mar 3, 2021

04:05PM EST Ampio Pharmaceuticals Reports FY20 EPS $(0.09) Up From $(0.14) YoY Benzinga

04:01PM EST Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and PR Newswire

09:15AM EST Ampio Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences PR Newswire

07:46AM EST The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study Benzinga

Feb 24, 2021

09:15AM EST Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide PR Newswire

Feb 23, 2021

09:17AM EST Ampio Says Brings New Hospitals Online In Trial For Inhalation Treatment Of COVID-19 With Ampion RTTNews

09:16AM EST Ampio Pharma Reports Addition Of 2 New Study Sites To Further Expand Its Ongoing US Phase I Clinical Trial For Inhalation Treatment Of COVID-19 With Ampion Benzinga

09:15AM EST Ampio Brings New Hospitals Online in Trial for Inhalation Treatment of COVID-19 PR Newswire

Feb 16, 2021

12:46PM EST 43 Stocks Moving In Tuesday's Mid-Day Session Benzinga

09:16AM EST Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference PR Newswire

Feb 1, 2021

09:44AM EST Ampio Pharmaceuticals Inc. (AMPE) announced early positive data from its ongoing U.S. Phase I controlled, observer-blinded clinical trial of inhaled Ampion compared to standard of care for patients with COVID-19 respiratory distress (AP-014). RTTNews

09:19AM EST Ampio Reports Early Positive Data In Phase 1 Trial Of Inhaled Ampion In COVID-19 Respiratory Distress RTTNews

09:17AM EST Ampio Announces 'Early Positive Data' In Phase 1 Trial Of Inhaled Ampion In COVID-19 Respiratory Distress Benzinga

09:15AM EST Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in PR Newswire

Jan 14, 2021

09:19AM EST Ampio Says Ongoing Phase I Clinical Trial For Inhalation Treatment Of COVID-19 With Ampion Is 55% Enrolled RTTNews

09:16AM EST Ampio Pharmaceuticals Says Ongoing Phase 1 Clinical Trial For Inhalation Treatment Of COVID-19 With Ampion Is 55% Enrolled Benzinga

09:16AM EST Ampio Pharmaceuticals Ongoing Phase I Clinical Trial for Inhalation Treatment PR Newswire

Jan 4, 2021

09:17AM EST Ampio Announces Initiation Of A Global Trial For IV Treatment Of COVID-19 Patients, Incl In Out-patient Settings RTTNews

09:15AM EST Ampio Provides Update on Clinical Trials for Ampion(tm) Treatment of COVID-19 PR Newswire

09:15AM EST Ampio Provides Update On Clinical Trials For Ampion Treatment Of COVID-19 Patients Benzinga

Dec 29, 2020

10:56AM EST Ampio Pharmaceuticals Inc. (AMPE) Tuesday said it received feedback from the FDA on its proposed modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee. RTTNews

09:23AM EST Ampio Gets Feedback From FDA On Proposed Modifications To Assessment For Ampion Treatment Of Severe OAK RTTNews

09:17AM EST Ampio Pharma Shares Feedback From FDA Related To Proposed Modifications To Special Protocol Assessment For Ampion Treatment For Severe Osteoarthritis Of The Knee Benzinga

09:15AM EST special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee PR Newswire

Dec 17, 2020

09:32AM EST Ampion Shows Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion RTTNews

09:16AM EST Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion Benzinga

09:15AM EST Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical PR Newswire

Dec 10, 2020

09:25AM EST Ampio Pharma Says Enters Into Two Collaborative Research Deals To Explore New Clinical Indications For Ampion RTTNews

09:16AM EST Ampio Enters Into Collaborative Research Agreements To Explore Additional Clinical Indications for Its Immunomodulatory Drug, Ampion Benzinga

09:15AM EST Ampio Enters into Collaborative Research Agreements to Explore Additional PR Newswire

Dec 8, 2020

09:16AM EST Ampio Pharmaceuticals, Inc. to Host its Annual Meeting on December 12, 2020 PR Newswire

Dec 2, 2020

09:16AM EST Ampio's PhaseI Study For Inhaled Ampion Advances To Completing Enrollment Of COVID-19 Patients With Respiratory Distress RTTNews

09:16AM EST Ampio's Phase I Study For Inhaled Ampion Advances To Completing Enrollment Of PR Newswire

Nov 25, 2020

09:24AM EST Ampio : Phase I Inhaled Ampion Clinical Trial To Accelerate To Complete Remaining Thirty-four Patients RTTNews

09:17AM EST UPDATE: Ampio Says Third Of Three Initial Safety Groups Of Patients Have Completed 4 Days Of Treatment, Three Days Of Follow Up For Phase 1 Ampion Clinical Trial Benzinga

09:15AM EST Ampio Updates Regulatory and Clinical Trial Events PR Newswire

Nov 17, 2020

09:21AM EST Ampio Says Phase I Study For Inhaled Ampion Advances To Third Group Of COVID-19 Patients With Respiratory Distress RTTNews

09:16AM EST Amipo Pharma Reports Third Group In Phase 1 Inhaled Ampion Study Being Treated Following Clearance By Safety Monitoring Committee Benzinga

09:15AM EST Ampio's Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 PR Newswire

Nov 10, 2020

04:16PM EST Ampio's Phase I Study For Inhaled Ampion Advances To 2nd Group Of Coronavirus Patients With Respiratory Distress Benzinga

04:01PM EST Ampio's Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 PR Newswire

Nov 5, 2020

03:47PM EST Ampio Pharmaceuticals Reports Q3 2020 R&D Costs Were $1.7M; Co Reports Net Loss Of $3.4M Benzinga

03:45PM EST Ampio Pharmaceuticals, Inc. Provides Business Update and Reports Third Quarter PR Newswire

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 2, 2020

09:15AM EST Ampio Pharmaceuticals, Inc. to Host Conference Call on November 5th PR Newswire

Oct 28, 2020

08:58AM EDT Ampio Pharmaceuticals Inc. (AMPE) said that it has begun phase 1 clinical trial of inhaled ampion for COVID-19 patients with respiratory distress. RTTNews

07:45AM EDT Ampio Commences Phase 1 Clinical Trial Of Inhaled Ampion For COVID-19 Patients With Respiratory Distress RTTNews

07:38AM EDT Ampio Begins Phase 1 Clinical Trial Of Inhaled Ampion For COVID-19 Patients With Respiratory Distress RTTNews

07:31AM EDT Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients PR Newswire

07:30AM EDT Ampio Begins Phase 1 Clinical Trial Of Inhaled Ampion For COVID-19 Patients With Respiratory Distress Benzinga

Oct 27, 2020

09:15AM EDT Ampio Pharmaceuticals, Inc. to Present at the ROTH Capital Healthcare Event PR Newswire

Oct 26, 2020

09:21AM EDT Ampio Presents At Roth Capital Partners 2020 MedTech Innovation Forum Focusing On COVID-19 Clinical Trial Activities Benzinga

09:15AM EDT Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing PR Newswire

Oct 8, 2020

09:16AM EDT Ampio Pharma Highlights Publication Of Scientific Manuscript On Effects Of Ampion On Peripheral Blood Monocytes Benzinga

09:16AM EDT Ampio Publication Reports Beneficial Effects of Ampion on Important PR Newswire

Sep 29, 2020

08:38AM EDT Theralink Technologies Appoints Thomas Chilcott As CFO Benzinga

Sep 25, 2020

03:10PM EDT Turning Base Hits Into Home-Run Trades Benzinga

Sep 22, 2020

08:14AM EDT Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Sept. 22, 2020: COST, ALB, CRSR, BLNK, AMPE Benzinga

Sep 21, 2020

09:29AM EDT Ampio : FDA Grants IND And Oks Clinical Trial Protocol Of Inhaled Ampion For COVID-19 Patients With Respiratory Distress RTTNews

09:16AM EDT FDA Grants IND, Approves Clinical Trial Protocol Of Inhaled Ampion For Coronavirus Patients With Respiratory Distress Benzinga

09:15AM EDT FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for PR Newswire

Sep 14, 2020

09:17AM EDT Ampio Pharmaceuticals Shares Spike After Co. Highlights Featuring Of Co.'s Phase I COVID-19 Patient Trial Results On FOX News Benzinga

09:15AM EDT Ampion Phase I COVID-19 Patient Trial Results Featured on FOX News (Video) PR Newswire

Sep 9, 2020

11:40AM EDT Shares of Ampio Pharmaceuticals Inc. (AMPE) gained over 8% on Wednesday morning after the company reported positive results from Ampion treatment for COVID-19 patients. RTTNews

09:35AM EDT Ampio Announces Positive Results In Early Trial For IV Ampion Treatment For COVID-19 Patients RTTNews

09:18AM EDT UPDATE: Ampio Highlights 'Ampion-treated patients showed greater improvement compared to patients treated with the standard of care including anti-viral therapies' Benzinga

09:17AM EDT UPDATE: Amipo Highlights 'Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scale' Benzinga

09:16AM EDT Ampio Reports Positive Results For Ampion Treatment In Coronvirus Patients Benzinga

09:15AM EDT Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients PR Newswire

Sep 4, 2020

09:31AM EDT Ampio Completes Enrollment For AmpionTM Phase I US Based Clinical Trial RTTNews

09:18AM EDT Ampio Gives Update On Osteoarthritis Of Knee Clinical Trial; Co Says Will Remain Blind To Trial Data To Comply With FDA Guidance On Trials Affected By COVID-19 Pandemic Benzinga

09:16AM EDT Ampio Announces Enrollment Completion For Intravenous COVID-19 Clinical Trial Benzinga

09:15AM EDT Trial & Provides Update on Osteoarthritis of the Knee ("OAK") Clinical Trial PR Newswire

Aug 19, 2020

08:47AM EDT Biopharmaceutical company Ampio Pharmaceuticals, Inc. (AMPE) on Wednesday provided an update regarding the COVID-19 clinical trial activities. RTTNews

08:15AM EDT Ampio Provides Updates Regarding Clinical Trials RTTNews

08:04AM EDT Ampio Provides Update On COVID-19 Clinical Trial Activities Benzinga

Jul 23, 2020

10:13AM EDT Mid-Morning Market Update: Markets Down; AT&T Earnings Beat Estimates Benzinga

08:06AM EDT Ampio Pharma Reports Initiation Of Patient Enrollment In Ampion Coronavirus Program Benzinga

08:01AM EDT Ampio Starts Patient Enrollment in its Ampion COVID-19 Program PR Newswire

Jul 20, 2020

08:05AM EDT Ampio Reports Publication On 'Potential Benefits Of Ampion For Treatment Of New COVID-19 Related Syndrome' Benzinga

08:01AM EDT Ampio Reports a Publication on the Potential Benefits of Ampion for Treatment PR Newswire

Share